TYBR Health Investor Deep Dive

TYBR Health is addressing the significant issue of post-operative healing and scarring in tendon and ligament surgeries, which can lead to chronic pain, further surgeries, and higher healthcare costs. Their solution is the B3 Gel, a bio-gel designed to promote better healing by preventing scarring and adhesions while supporting faster recovery. TYBR plans to submit for FDA 510(k) clearance by Q4 2024 and conduct clinical pilot studies to validate the product's effectiveness, with a commercial launch expected post-clearance. Their go-to-market strategy targets orthopedic surgeons through medical conferences and peer discussions, with initial sales projected to 17 early adopters. TYBR has already made progress in product development, scaling manufacturing, and establishing a clear regulatory path, positioning them for growth and expansion into additional surgical markets.

https://tybrhealth.com/

TYBR Health is seeking $2M to submit for FDA 510(k) clearance and execute clinical pilots. TYBR Health is raising preferred equity at a $15M pre-money valuation.

TYBR Health Pitch Deck

TYBR Health Investor Response Report

The purpose of this meeting is to meet face-to-face with the company executive leadership team in order to get crucial questions answered.  The Deep Dive will take place virtually and will cover all the major due diligence questions such as IP, competition, leadership, funding strategy, exit strategy, use of funds, milestones, etc.

The format for the Deep Dive will be as follows:

Company Long-Form Pitch & Q&A w/ Investors (60 Minutes)

Optional - Investor Only Discussion (30 Minutes)

_____________________________________________

Investor Deep Dive

Date: October 28th, 2024

Virtual Attendance available via Zoom

Time: 3:00pm to 4:30pm MST

 __________________________________________

To attend, you must be an accredited investor (net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 together with his or her spouse if married] and have the expectation to make the same amount this year). We do not require a minimum investment.